The role of bleomycin and dacarbazine in the ABVD regimen ( ie , doxorubicin , bleomycin , vinblastine , and dacarbazine ) has been questioned , especially for treatment of early-stage favourable Hodgkin 's lymphoma , because of the drugs ' toxicity .